318 related articles for article (PubMed ID: 23180366)
1. Suppression of MAPK and NF-κB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury.
Chi G; Wei M; Xie X; Soromou LW; Liu F; Zhao S
Inflammation; 2013 Apr; 36(2):501-11. PubMed ID: 23180366
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
[TBL] [Abstract][Full Text] [Related]
3. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice.
Xie X; Sun S; Zhong W; Soromou LW; Zhou X; Wei M; Ren Y; Ding Y
Int Immunopharmacol; 2014 Mar; 19(1):103-9. PubMed ID: 24412620
[TBL] [Abstract][Full Text] [Related]
4. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
Jing W; Chunhua M; Shumin W
Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
[TBL] [Abstract][Full Text] [Related]
5. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice.
Chen J; Wang JB; Yu CH; Chen LQ; Xu P; Yu WY
J Ethnopharmacol; 2013 Jul; 148(3):835-41. PubMed ID: 23747643
[TBL] [Abstract][Full Text] [Related]
6. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
[TBL] [Abstract][Full Text] [Related]
7. Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways.
Liu F; Sun GQ; Gao HY; Li RS; Soromou LW; Chen N; Deng YH; Feng HH
J Surg Res; 2013 Nov; 185(1):300-9. PubMed ID: 23816246
[TBL] [Abstract][Full Text] [Related]
8. Suppression of P2X7/NF-κB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury.
Cai Z; Liu J; Bian H; Cai J; Zhu G
Arch Pharm Res; 2016 Apr; 39(4):499-507. PubMed ID: 26832323
[TBL] [Abstract][Full Text] [Related]
9. Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach.
Peritore AF; D'Amico R; Siracusa R; Cordaro M; Fusco R; Gugliandolo E; Genovese T; Crupi R; Di Paola R; Cuzzocrea S; Impellizzeri D
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073872
[TBL] [Abstract][Full Text] [Related]
10. Cyanidin-3-O-Glucoside Ameliorates Lipopolysaccharide-Induced Injury Both In Vivo and In Vitro Suppression of NF-κB and MAPK Pathways.
Ma MM; Li Y; Liu XY; Zhu WW; Ren X; Kong GQ; Huang X; Wang LP; Luo LQ; Wang XZ
Inflammation; 2015 Aug; 38(4):1669-82. PubMed ID: 25752620
[TBL] [Abstract][Full Text] [Related]
11. Stevioside protects LPS-induced acute lung injury in mice.
Yingkun N; Zhenyu W; Jing L; Xiuyun L; Huimin Y
Inflammation; 2013 Feb; 36(1):242-50. PubMed ID: 22968433
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice.
Liu Z; Yang Z; Fu Y; Li F; Liang D; Zhou E; Song X; Zhang W; Zhang X; Cao Y; Zhang N
Inflamm Res; 2013 May; 62(5):499-506. PubMed ID: 23435932
[TBL] [Abstract][Full Text] [Related]
13. Protocatechuic acid attenuates lipolysaccharide-induced acute lung injury.
Wei M; Chu X; Jiang L; Yang X; Cai Q; Zheng C; Ci X; Guan M; Liu J; Deng X
Inflammation; 2012 Jun; 35(3):1169-78. PubMed ID: 22466397
[TBL] [Abstract][Full Text] [Related]
14. Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice.
Chen Y; Guo S; Jiang K; Wang Y; Yang M; Guo M
Int Immunopharmacol; 2019 Oct; 75():105749. PubMed ID: 31306981
[TBL] [Abstract][Full Text] [Related]
15. Ginkgo biloba extracts attenuate lipopolysaccharide-induced inflammatory responses in acute lung injury by inhibiting the COX-2 and NF-κB pathways.
Yao X; Chen N; Ma CH; Tao J; Bao JA; Zong-Qi C; Chen ZT; Miao LY
Chin J Nat Med; 2015 Jan; 13(1):52-8. PubMed ID: 25660288
[TBL] [Abstract][Full Text] [Related]
16. Sangxingtang inhibits the inflammation of LPS-induced acute lung injury in mice by down-regulating the MAPK/NF-κB pathway.
Zhang TZ; Yang SH; Yao JF; Du J; Yan TH
Chin J Nat Med; 2015 Dec; 13(12):889-95. PubMed ID: 26721707
[TBL] [Abstract][Full Text] [Related]
17. Suppression of NLRP3 and NF-κB signaling pathways by α-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice.
Liu X; Jin X; Yu D; Liu G
Int Immunopharmacol; 2019 Nov; 76():105886. PubMed ID: 31520990
[TBL] [Abstract][Full Text] [Related]
18. Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B.
Liang XM; Guo GF; Huang XH; Duan WL; Zeng ZL
J Surg Res; 2014 Apr; 187(2):596-604. PubMed ID: 24331940
[TBL] [Abstract][Full Text] [Related]
19. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKT, and NF-κB signaling pathways.
Yu X; Yu S; Chen L; Liu H; Zhang J; Ge H; Zhang Y; Yu B; Kou J
Biomed Pharmacother; 2016 Aug; 82():489-97. PubMed ID: 27470389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
